希望教育(01765.HK)續挫近9% 擬發CB及折讓近一成配股籌約46億元
希望教育(01765.HK)擬發CB及折讓近一成配股,該股逆市三連跌,今早股價失守20天線及曾失配股價,最低見2.75元,現造2.83元,續挫8.7%,成交受配股上板帶動急增至8.81億股,涉資24.76億元。
希望教育公布,擬以每股2.8元(較昨天收市價折讓約9.7%)先舊後先方式配售6.8億股或佔擴大後股本8.53%。另外,擬發行本金總額3.5億美元於2026年到期零息可轉換債券(CB),基於初始換股價3.85元及固定匯率並假設債券按初始換股價全面兌換,CB將兌換為7.05億股或佔擴大後股本8.81%。合共集資約46億元,主要用於業務擴張及營運資金等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.